Accuray Incorporated (ARAY)

medical devices vom feinsten,sehr guenstig;

Accuray Incorporated (ARAY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
Quote Lookup

2.8200-0.0700 (-2.42%)
At close: August 19 04:00PM EDT

Zacks Equity Research
Fri, August 19, 2022 at 1:44 PM
In this article:

ARAY
-2.42%

Investors in Accuray Incorporated ARAY need to pay close attention to the stock based on moves in the options market lately. That is because the Sep 16, 2022 $1.00 Call had some of the highest implied volatility of all equity options today.

What is Implied Volatility?
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.

What do the Analysts Think?
Clearly, options traders are pricing in a big move for Accuray shares, but what is the fundamental picture for the company? Currently, Accuray is a Zacks Rank #3 (Hold) in the Medical - Instruments industry that ranks in Bottom 45% of our Zacks Industry Rank. Over the last 60 days, the Zacks Consensus Estimate for the current quarter has moved from earnings of 1 cent per share to a loss of 1 cent.

Given the way analysts feel about Accuray right now, this huge implied volatility could mean there’s a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.

Looking to Trade Options?        
Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney. The company also provides the TomoTherapy System, including the Radixact System, which consists of an integrated radiation therapy system designed for the treatment of a range of cancer types. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California.

Appreciate the entire Accuray experience: "They come up with new technologies. Easy to use system." "They treat linear tumors better than any machines I know of." "Accuray by far has been the easiest machine to learn to work on."

"Our goal is to provide our customers with more than just a machine. We strive to build partnerships that continue throughout the life of our products and create confidence in our organization and our team – through upgrade paths that keep customers on the forefront of technology, service that never quits, and ongoing opportunities for education," said Scott Chapman, senior vice president, global service at Accuray. "According to IMV, this most recent report marks the third consecutive year we have seen an increase in the percent of customers likely to repurchase an Accuray radiation delivery system, suggesting the company's focus and our team's commitment to excellence in meeting customers' needs is on track."